- The report also points out studies showing that ingesting CBD could cause liver damage and interactions with medications a person might be taking.
- The FDA also sent out a press release with warnings to 15 companies stating how they are in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
- The press release specifically points to the fact that these companies are labeling products containing CBD as dietary supplements and also claiming that their products can treat and/ or cure disease.
- ” As we work quickly to further clarify our regulatory approach for products containing cannabis and cannabis-derived compounds like CBD, we’ll continue to monitor the marketplace and take action as needed against companies that violate the law in ways that raise a variety of public health concerns.
Read full article: marijuanatimes.org